(1) Net cash used in operating activities for the three months ended June 30, 2017 of $7.1 million includes the impact of payments of $18.0 million in assumed Exar pre-close liabilities and $7.6 million in aggregate transaction and cash restructuring costs.
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) | |||||||
Six Months Ended | |||||||
June 30, 2017 | June 30, 2016 | ||||||
Operating Activities | |||||||
Net income | $ | 19,428 | $ | 43,265 | |||
Adjustments to reconcile net income to cash provided by operating activities: | |||||||
Amortization and depreciation | 25,160 | 9,935 | |||||
Provision for losses on accounts receivable | 87 | — | |||||
Amortization (accretion) of investment premiums (discount), net | (60 | ) | 83 | ||||
Amortization of inventory step-up | 5,635 | 336 | |||||
Amortization of debt issuance costs | 175 | — | |||||
Stock-based compensation | 17,102 | 10,211 | |||||
Deferred income taxes | (53,142 | ) | 133 | ||||
(Gain) loss on disposal of property and equipment | (85 | ) | 48 | ||||
(Gain) loss on sale of available-for-sale securities | 38 | (50 | ) | ||||
(Gain) loss on foreign currency | 682 | (46 | ) | ||||
Excess tax benefits on stock-based awards | (3,290 | ) | (5,114 | ) | |||
Change in fair value of contingent consideration | — | 110 | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | (20,932 | ) | (1,941 | ) | |||
Inventory | (7,391 | ) | 7,418 | ||||
Prepaid expenses and other assets | 5,210 | (805 | ) | ||||
Accounts payable, accrued expenses and other current liabilities | 15,562 | 4,967 | |||||
Accrued compensation | (1,282 | ) | 3,540 | ||||
Deferred revenue and deferred profit | 7,326 | 1,732 | |||||
Accrued price protection liability | 9,447 | (1,756 | ) | ||||
Other long-term liabilities | (4,088 | ) | (767 | ) | |||
Net cash provided by operating activities | 15,582 | 71,299 | |||||
Investing Activities | |||||||
Purchases of property and equipment | (1,898 | ) | (4,710 | ) | |||
Purchases of intangible assets | (5,325 | ) | (390 | ) | |||
Cash used in acquisition, net of cash acquired | (473,304 | ) | (21,000 | ) | |||
Purchases of available-for-sale securities | (30,577 | ) | (47,277 | ) | |||
Maturities of available-for-sale securities | 84,546 | 81,011 | |||||
Net cash provided by (used in) investing activities | (426,558 | ) | 7,634 | ||||
Financing Activities | |||||||
Repurchases of common stock | (334 | ) | (3 | ) | |||
Net proceeds from issuance of common stock | 8,018 | 4,285 | |||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (8,399 | ) | (3,593 | ) | |||
Proceeds from issuance of debt | 416,846 | — | |||||
Net cash provided by financing activities | 416,131 | 689 | |||||
Effect of exchange rate changes on cash and cash equivalents | 2,040 | 4 | |||||
Increase in cash, cash equivalents and restricted cash | 7,195 | 79,626 | |||||
Cash, cash equivalents and restricted cash at beginning of period | 82,896 | 67,956 | |||||
Cash, cash equivalents and restricted cash at end of period | $ | 90,091 | $ | 147,582 |